Report cover image

Global MET TKIs Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 200 Pages
SKU # APRC20282934

Description

Summary

According to APO Research, The global MET TKIs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of MET TKIs include Wanbang Biopharmaceuticals, CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Zydus and Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for MET TKIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of MET TKIs, also provides the sales of main regions and countries. Of the upcoming market potential for MET TKIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the MET TKIs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global MET TKIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for MET TKIs sales, projected growth trends, production technology, application and end-user industry.

MET TKIs Segment by Company

Wanbang Biopharmaceuticals
CSPC Pharmaceutical
Asymchem
Shanghai Hutchison Pharmaceuticals
WuXi STA
Haihe Biopharma
Avistone Pharmaceuticals Biotechnology
Zydus
Teva
Pfizer
Novartis
Merck
Genvio Pharma
Exelixis
Everest Pharmaceuticals
Drug International
Cipla
Beacom
BDR Pharma
MET TKIs Segment by Type

Multi-target Inhibitors
Single-target Inhibitors
MET TKIs Segment by Application

Non-small Cell Lung Cancer
Medullary Thyroid Cancer
Other
MET TKIs Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MET TKIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of MET TKIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of MET TKIs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, MET TKIs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

200 Pages
1 Market Overview
1.1 Product Definition
1.2 MET TKIs Market by Type
1.2.1 Global MET TKIs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Multi-target Inhibitors
1.2.3 Single-target Inhibitors
1.3 MET TKIs Market by Application
1.3.1 Global MET TKIs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Non-small Cell Lung Cancer
1.3.3 Medullary Thyroid Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 MET TKIs Market Dynamics
2.1 MET TKIs Industry Trends
2.2 MET TKIs Industry Drivers
2.3 MET TKIs Industry Opportunities and Challenges
2.4 MET TKIs Industry Restraints
3 Global Market Growth Prospects
3.1 Global MET TKIs Revenue Estimates and Forecasts (2020-2031)
3.2 Global MET TKIs Revenue by Region
3.2.1 Global MET TKIs Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global MET TKIs Revenue by Region (2020-2025)
3.2.3 Global MET TKIs Revenue by Region (2026-2031)
3.2.4 Global MET TKIs Revenue Market Share by Region (2020-2031)
3.3 Global MET TKIs Sales Estimates and Forecasts 2020-2031
3.4 Global MET TKIs Sales by Region
3.4.1 Global MET TKIs Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global MET TKIs Sales by Region (2020-2025)
3.4.3 Global MET TKIs Sales by Region (2026-2031)
3.4.4 Global MET TKIs Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global MET TKIs Revenue by Manufacturers
4.1.1 Global MET TKIs Revenue by Manufacturers (2020-2025)
4.1.2 Global MET TKIs Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global MET TKIs Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global MET TKIs Sales by Manufacturers
4.2.1 Global MET TKIs Sales by Manufacturers (2020-2025)
4.2.2 Global MET TKIs Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global MET TKIs Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global MET TKIs Sales Price by Manufacturers (2020-2025)
4.4 Global MET TKIs Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global MET TKIs Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global MET TKIs Manufacturers, Product Type & Application
4.7 Global MET TKIs Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global MET TKIs Market CR5 and HHI
4.8.2 2024 MET TKIs Tier 1, Tier 2, and Tier 3
5 MET TKIs Market by Type
5.1 Global MET TKIs Revenue by Type
5.1.1 Global MET TKIs Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global MET TKIs Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global MET TKIs Revenue Market Share by Type (2020-2031)
5.2 Global MET TKIs Sales by Type
5.2.1 Global MET TKIs Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global MET TKIs Sales by Type (2020-2031) & (K Units)
5.2.3 Global MET TKIs Sales Market Share by Type (2020-2031)
5.3 Global MET TKIs Price by Type
6 MET TKIs Market by Application
6.1 Global MET TKIs Revenue by Application
6.1.1 Global MET TKIs Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global MET TKIs Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global MET TKIs Revenue Market Share by Application (2020-2031)
6.2 Global MET TKIs Sales by Application
6.2.1 Global MET TKIs Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global MET TKIs Sales by Application (2020-2031) & (K Units)
6.2.3 Global MET TKIs Sales Market Share by Application (2020-2031)
6.3 Global MET TKIs Price by Application
7 Company Profiles
7.1 Wanbang Biopharmaceuticals
7.1.1 Wanbang Biopharmaceuticals Comapny Information
7.1.2 Wanbang Biopharmaceuticals Business Overview
7.1.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
7.1.5 Wanbang Biopharmaceuticals Recent Developments
7.2 CSPC Pharmaceutical
7.2.1 CSPC Pharmaceutical Comapny Information
7.2.2 CSPC Pharmaceutical Business Overview
7.2.3 CSPC Pharmaceutical MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CSPC Pharmaceutical MET TKIs Product Portfolio
7.2.5 CSPC Pharmaceutical Recent Developments
7.3 Asymchem
7.3.1 Asymchem Comapny Information
7.3.2 Asymchem Business Overview
7.3.3 Asymchem MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Asymchem MET TKIs Product Portfolio
7.3.5 Asymchem Recent Developments
7.4 Shanghai Hutchison Pharmaceuticals
7.4.1 Shanghai Hutchison Pharmaceuticals Comapny Information
7.4.2 Shanghai Hutchison Pharmaceuticals Business Overview
7.4.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
7.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments
7.5 WuXi STA
7.5.1 WuXi STA Comapny Information
7.5.2 WuXi STA Business Overview
7.5.3 WuXi STA MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 WuXi STA MET TKIs Product Portfolio
7.5.5 WuXi STA Recent Developments
7.6 Haihe Biopharma
7.6.1 Haihe Biopharma Comapny Information
7.6.2 Haihe Biopharma Business Overview
7.6.3 Haihe Biopharma MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Haihe Biopharma MET TKIs Product Portfolio
7.6.5 Haihe Biopharma Recent Developments
7.7 Avistone Pharmaceuticals Biotechnology
7.7.1 Avistone Pharmaceuticals Biotechnology Comapny Information
7.7.2 Avistone Pharmaceuticals Biotechnology Business Overview
7.7.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
7.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments
7.8 Zydus
7.8.1 Zydus Comapny Information
7.8.2 Zydus Business Overview
7.8.3 Zydus MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Zydus MET TKIs Product Portfolio
7.8.5 Zydus Recent Developments
7.9 Teva
7.9.1 Teva Comapny Information
7.9.2 Teva Business Overview
7.9.3 Teva MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Teva MET TKIs Product Portfolio
7.9.5 Teva Recent Developments
7.10 Pfizer
7.10.1 Pfizer Comapny Information
7.10.2 Pfizer Business Overview
7.10.3 Pfizer MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Pfizer MET TKIs Product Portfolio
7.10.5 Pfizer Recent Developments
7.11 Novartis
7.11.1 Novartis Comapny Information
7.11.2 Novartis Business Overview
7.11.3 Novartis MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Novartis MET TKIs Product Portfolio
7.11.5 Novartis Recent Developments
7.12 Merck
7.12.1 Merck Comapny Information
7.12.2 Merck Business Overview
7.12.3 Merck MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Merck MET TKIs Product Portfolio
7.12.5 Merck Recent Developments
7.13 Genvio Pharma
7.13.1 Genvio Pharma Comapny Information
7.13.2 Genvio Pharma Business Overview
7.13.3 Genvio Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Genvio Pharma MET TKIs Product Portfolio
7.13.5 Genvio Pharma Recent Developments
7.14 Exelixis
7.14.1 Exelixis Comapny Information
7.14.2 Exelixis Business Overview
7.14.3 Exelixis MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Exelixis MET TKIs Product Portfolio
7.14.5 Exelixis Recent Developments
7.15 Everest Pharmaceuticals
7.15.1 Everest Pharmaceuticals Comapny Information
7.15.2 Everest Pharmaceuticals Business Overview
7.15.3 Everest Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Everest Pharmaceuticals MET TKIs Product Portfolio
7.15.5 Everest Pharmaceuticals Recent Developments
7.16 Drug International
7.16.1 Drug International Comapny Information
7.16.2 Drug International Business Overview
7.16.3 Drug International MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Drug International MET TKIs Product Portfolio
7.16.5 Drug International Recent Developments
7.17 Cipla
7.17.1 Cipla Comapny Information
7.17.2 Cipla Business Overview
7.17.3 Cipla MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Cipla MET TKIs Product Portfolio
7.17.5 Cipla Recent Developments
7.18 Beacom
7.18.1 Beacom Comapny Information
7.18.2 Beacom Business Overview
7.18.3 Beacom MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Beacom MET TKIs Product Portfolio
7.18.5 Beacom Recent Developments
7.19 BDR Pharma
7.19.1 BDR Pharma Comapny Information
7.19.2 BDR Pharma Business Overview
7.19.3 BDR Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 BDR Pharma MET TKIs Product Portfolio
7.19.5 BDR Pharma Recent Developments
8 North America
8.1 North America MET TKIs Market Size by Type
8.1.1 North America MET TKIs Revenue by Type (2020-2031)
8.1.2 North America MET TKIs Sales by Type (2020-2031)
8.1.3 North America MET TKIs Price by Type (2020-2031)
8.2 North America MET TKIs Market Size by Application
8.2.1 North America MET TKIs Revenue by Application (2020-2031)
8.2.2 North America MET TKIs Sales by Application (2020-2031)
8.2.3 North America MET TKIs Price by Application (2020-2031)
8.3 North America MET TKIs Market Size by Country
8.3.1 North America MET TKIs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America MET TKIs Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America MET TKIs Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe MET TKIs Market Size by Type
9.1.1 Europe MET TKIs Revenue by Type (2020-2031)
9.1.2 Europe MET TKIs Sales by Type (2020-2031)
9.1.3 Europe MET TKIs Price by Type (2020-2031)
9.2 Europe MET TKIs Market Size by Application
9.2.1 Europe MET TKIs Revenue by Application (2020-2031)
9.2.2 Europe MET TKIs Sales by Application (2020-2031)
9.2.3 Europe MET TKIs Price by Application (2020-2031)
9.3 Europe MET TKIs Market Size by Country
9.3.1 Europe MET TKIs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe MET TKIs Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe MET TKIs Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China MET TKIs Market Size by Type
10.1.1 China MET TKIs Revenue by Type (2020-2031)
10.1.2 China MET TKIs Sales by Type (2020-2031)
10.1.3 China MET TKIs Price by Type (2020-2031)
10.2 China MET TKIs Market Size by Application
10.2.1 China MET TKIs Revenue by Application (2020-2031)
10.2.2 China MET TKIs Sales by Application (2020-2031)
10.2.3 China MET TKIs Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia MET TKIs Market Size by Type
11.1.1 Asia MET TKIs Revenue by Type (2020-2031)
11.1.2 Asia MET TKIs Sales by Type (2020-2031)
11.1.3 Asia MET TKIs Price by Type (2020-2031)
11.2 Asia MET TKIs Market Size by Application
11.2.1 Asia MET TKIs Revenue by Application (2020-2031)
11.2.2 Asia MET TKIs Sales by Application (2020-2031)
11.2.3 Asia MET TKIs Price by Application (2020-2031)
11.3 Asia MET TKIs Market Size by Country
11.3.1 Asia MET TKIs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia MET TKIs Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia MET TKIs Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA MET TKIs Market Size by Type
12.1.1 SAMEA MET TKIs Revenue by Type (2020-2031)
12.1.2 SAMEA MET TKIs Sales by Type (2020-2031)
12.1.3 SAMEA MET TKIs Price by Type (2020-2031)
12.2 SAMEA MET TKIs Market Size by Application
12.2.1 SAMEA MET TKIs Revenue by Application (2020-2031)
12.2.2 SAMEA MET TKIs Sales by Application (2020-2031)
12.2.3 SAMEA MET TKIs Price by Application (2020-2031)
12.3 SAMEA MET TKIs Market Size by Country
12.3.1 SAMEA MET TKIs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA MET TKIs Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA MET TKIs Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 MET TKIs Value Chain Analysis
13.1.1 MET TKIs Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 MET TKIs Production Mode & Process
13.2 MET TKIs Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 MET TKIs Distributors
13.2.3 MET TKIs Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.